Ani Pharmaceuticals Inc (ANIP)
Equity Ratio
39.97%
Quarterly · Period ending:
ANIP Equity Ratio
Latest reported39.97%period ending
Latest reported39.97%period ending
ANIP Quarterly Equity Ratio (94.59% → 39.97%)
Latest values, visible window
High-resolution chart · PNG
ANIP equity ratio history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Equity Ratio |
|---|---|
| 39.971% | |
| 39.5437% | |
| 37.5404% | |
| 35.9206% | |
| 34.3713% | |
| 34.3129% | |
| 33.3825% | |
| 33.4632% | |
| 52.1975% | |
| 52.1378% | |
| 50.5957% | |
| 51.0961% | |
| 50.5587% | |
| 44.3637% | |
| 44.5396% | |
| 45.5514% | |
| 44.848% | |
| 46.4652% | |
| 46.4931% | |
| 40.6847% | |
| 39.9695% | |
| 43.9183% | |
| 42.4337% | |
| 42.1764% | |
| 41.1147% | |
| 41.7166% | |
| 46.5841% | |
| 46.6597% | |
| 46.4653% | |
| 45.9753% | |
| 45.8108% | |
| 43.7975% | |
| 43.6398% | |
| 42.9751% | |
| 42.4023% | |
| 49.3431% | |
| 49.1472% | |
| 48.22% | |
| 52.5447% | |
| 52.862% | |
| 53.1742% | |
| 54.933% | |
| 56.1169% | |
| 55.0322% | |
| 55.3456% | |
| 54.4166% | |
| 53.0073% | |
| 92.4329% | |
| 95.9884% | |
| 95.282% | |
| 92.0494% | |
| 84.7594% | |
| 85.2052% | |
| 73.6236% | |
| 72.675% | |
| 74.7243% | |
| 65.3795% | |
| 69.6224% | |
| 60.6211% | |
| 58.9509% | |
| 26.9632% | |
| 46.0096% | |
| 42.771% | |
| 37.5431% | |
| 51.4175% | |
| 48.6212% | |
| 43.446% | |
| 70.0656% | |
| 60.9997% | |
| 76.5075% | |
| 78.2065% | |
| 76.9434% | |
| 85.1154% | |
| 89.8083% | |
| 95.1479% | |
| 93.3119% | |
| 92.5742% | |
| 87.2393% | |
| 80.7803% | |
| 84.1083% | |
| 52.5789% | |
| 62.7127% | |
| 71.2183% | |
| 85.0968% | |
| 87.5872% | |
| 88.0924% | |
| 89.3043% | |
| 93.6593% | |
| 94.9636% | |
| 86.7774% | |
| 90.7876% | |
| 93.5753% | |
| 73.6969% | |
| 85.8947% | |
| 78.635% | |
| 88.0153% | |
| 65.6567% | |
| 81.2925% | |
| 81.3674% | |
| 84.1504% |